Oxidative stress markers in patients with hymenoptera venom allergy.

Abstract:

:Oxidative stress occurs in many allergic and immunologic disorders as a result of the imbalance between the endogenous production of free reactive oxygen species (ROS) and/or the reduction of antioxidant defense mechanisms. Advanced glycation end products (AGEs), advanced oxidation protein products (AOPPs), and nitrosylated proteins (NPs) can be used as markers of oxidative stress and inflammation. Our objective was to examine the serum levels of AGEs, AOPPs, and NPs in patients with allergic reactions to hymenoptera venom before and after ultrarush venom immunotherapy (VIT). The study included two groups of patients: 30 patients allergic to yellow jacket or honey bee venom and treated by aqueous preparation of Vespula spp (26 patients) or Apis mellifera (four patients) VIT, and 30 healthy donors as controls. Blood samples were collected to measure serum levels of AGEs, AOPPs, and NPs at baseline (T1), at the end of the incremental phase of the VIT protocol (T2), and after 15 days (T3). Serum AOPP levels at T1 were significantly higher in comparison with controls (p = 0.001), whereas serum levels of NPs at T1 were significantly lower than those in controls (p < 0.0001). No significant difference in circulating levels of AOPPs, AGEs, and NPs was found during immunotherapy. These findings suggest that, although hymenoptera venom allergy (HVA) is characterized by isolated episodes of reactions to stinging insect venom and is not included among chronic inflammatory diseases, an oxidative stress status occurs in patients suffering from this kind of allergy. Furthermore, VIT does not modify serum levels of these oxidative stress biomarkers.

journal_name

Allergy Asthma Proc

authors

Patella V,Incorvaia C,Minciullo PL,Oricchio C,Saitta S,Florio G,Saija A,Gangemi S

doi

10.2500/aap.2015.36.3814

subject

Has Abstract

pub_date

2015-01-01 00:00:00

pages

9-13

issue

1

eissn

1088-5412

issn

1539-6304

journal_volume

36

pub_type

杂志文章
  • Hidden factors in asthma.

    abstract::The importance of discovering and treating hidden factors that exacerbate asthma as specified in component 2 of the 1997 National Heart Lung and Blood Institute (NHLBI) expert panel report guidelines has been overshadowed by a disproportionate emphasis on component 3 (pharmacologic therapy). This has resulted in disea...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,评审

    doi:

    authors: Somerville LL

    更新日期:2001-11-01 00:00:00

  • Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis.

    abstract::Background: GSP301 is an investigational fixed-dose combination nasal spray that contains the antihistamine, olopatadine hydrochloride (HCl), and the corticosteroid, mometasone furoate. Objective: To evaluate the efficacy and safety of GSP301 in patients with seasonal allergic rhinitis (SAR). Methods: In this double-b...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,随机对照试验

    doi:10.2500/aap.2019.40.4223

    authors: Hampel FC,Pedinoff AJ,Jacobs RL,Caracta CF,Tantry SK

    更新日期:2019-07-03 00:00:00

  • National estimates of emergency department visits for angioedema and allergic reactions in the United States.

    abstract::Each year there are a substantial number of emergency department (ED) visits for angioedema and allergic reactions in the United States. Angioedema is commonly mistaken for an allergic reaction, possibly affecting the treatment rendered. We sought to determine the characteristics of U.S. ED visits for acute angioedema...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2013.34.3640

    authors: Kelly M,Donnelly JP,McAnnally JR,Wang HE

    更新日期:2013-03-01 00:00:00

  • Do inhaled corticosteroid/long-acting beta2-agonist fixed combinations provide superior clinical benefits compared with separate inhalers? A literature reappraisal.

    abstract::Current asthma management guidelines emphasize the importance of disease control. Although effective drug therapies are available, real-life data indicate that the general level of asthma control is still low. Fixed-dose combinations of inhaled corticosteroids/long-acting beta(2)-agonists (ICS/LABAs) are now increasin...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,评审

    doi:10.2500/aap.2012.33.3512

    authors: Barnes PJ,Nicolini G,Bizzi A,Spinola M,Singh D

    更新日期:2012-03-01 00:00:00

  • Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy.

    abstract::Anti-IgE therapy with omalizumab, a recombinant humanized monoclonal antibody, has anti-inflammatory effects in allergic asthma and rhinitis. Although omalizumab has been exceptionally safe, reactions after its administration have been reported. The goal of this study was to assess two patients who experienced apparen...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2007.28.3003

    authors: Price KS,Hamilton RG

    更新日期:2007-05-01 00:00:00

  • Efficacy and tolerability study of ciclesonide nasal aerosol in patients with perennial allergic rhinitis.

    abstract::A new nasal aerosol solution formulation of ciclesonide containing a hydrofluoroalkane propellant (CIC-HFA) delivered via a metered-dose inhaler is currently in clinical development as a potential treatment for allergic rhinitis (AR). This study evaluated the efficacy and tolerability of CIC-HFA 74- or 148-microgram d...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.2500/aap.2012.33.3522

    authors: Mohar D,Berger WE,Laforce C,Raphael G,Desai SY,Huang H,Hinkle J

    更新日期:2012-01-01 00:00:00

  • Immunobiologic treatments for severe asthma, atopic dermatitis, and chronic urticaria.

    abstract::Immunobiologic agents are an important therapeutic alternative for severe asthma, atopic dermatitis, and chronic urticaria. In this article, we reviewed the most relevant studies that addressed the use of anti-immunoglobulin E (omalizumab), anti-IL-5 (mepolizumab, reslizumab, and benralizumab), and anti-IL-4/IL-13 (du...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,评审

    doi:10.2500/aap.2019.40.4277

    authors: Chiarella SE

    更新日期:2019-11-01 00:00:00

  • Prevalence of IgE reactivities in mold-allergic subjects to commercially available fungal enzymes.

    abstract::Fungi are important aeroallergens. However, fungal allergen sources of consistent quality for clinical testing are not readily available. Because some allergens have been identified as enzymes, we assessed the prevalence of IgE reactivity to commercially available fungal enzymes. The purpose of this study was to deter...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2008.29.3174

    authors: Horner WE,Armstrong M,El-Dahr J,McCants M,Reese G,Kobernick AK,Lehrer SB

    更新日期:2008-11-01 00:00:00

  • Asthma burden in the United States: results of the 2009 Asthma Insight and Management survey.

    abstract::Updated guidelines and new treatments for asthma have become available since the last major survey of asthma management in the United States was completed ∼11 years ago. The Asthma Insight and Management (AIM) survey was conducted to assess the current status of asthma burden in the United States. A geographically str...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2011.32.3519

    authors: Meltzer EO,Blaiss MS,Nathan RA,Doherty DE,Murphy KR,Stoloff SW

    更新日期:2012-01-01 00:00:00

  • Purified natural rubber latex antigens show variable reactivity with IgE in the sera of latex allergic patients.

    abstract::Immediate-hypersensitivity reactions related to latex products have increased rapidly in recent years. However, a reliable diagnosis is hampered by lack of purified and well characterized latex allergens. We have purified allergens in natural rubber latex (NRL) after SDS-PAGE by electroelution, and tested specific IgE...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/108854196778996921

    authors: Lu L,Kurup VP,Kelly KJ,Fink JN

    更新日期:1996-07-01 00:00:00

  • Allergic bronchopulmonary aspergillosis in an HIV-infected individual.

    abstract::Aspergilloma and invasive aspergillosis have been reported in HIV-infected individuals. Allergic Bronchopulmonary Aspergillosis (ABPA) is a lung disease marked by a hypersensitivity response to inhaled aspergillus species, most commonly Aspergillus fumigatus (Af). This manifestation of Af has previously not been repor...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/108854100778249051

    authors: Jain M

    更新日期:2000-11-01 00:00:00

  • Effect of staphylococcal enterotoxin B on specific antibody production in children with atopic dermatitis.

    abstract::Exotoxins secreted by Staphylococcus aureus have been identified as a possible trigger factor in atopic dermatitis (AD). We investigated the production and role of circulating antibodies, with specificity to staphylococcal enterotoxin B (SEB), in children with AD compared with those of healthy controls. The children w...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:

    authors: Sohn MH,Kim CH,Kim WK,Jang GC,Kim KE

    更新日期:2003-01-01 00:00:00

  • Rationale for the clinical use of a ribosome-component immune modulator.

    abstract::Vaccines have long been used to boost the immune system and to confer protection against microbial infections. In contrast, immunotherapy based on ribosomal preparations has been proposed to enhance both specific and nonspecific immune responses (in particular, the mucosal immune defense system) against common respira...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,评审

    doi:10.2500/aap.2009.30.3249

    authors: Pregliasco F,Terracciano L,Marcassa S,Zava D,Anselmi G

    更新日期:2009-07-01 00:00:00

  • Forced oscillometry is applicable to epidemiological settings to detect asthmatic children.

    abstract::Forced oscillometry (FOT) has been reported as a simple method to detect respiratory resistance (Rrs) changes. The aim of this study was to evaluate FOT capacity to detect children with clinical characteristics of asthma in a school setting. One thousand thirty children, 6-7 years old, were investigated by questionnai...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,多中心研究

    doi:10.2500/aap.2007.28.2965

    authors: Boccaccino A,Peroni DG,Pietrobelli A,Piacentini GL,Aversano MP,Spinosa E,Boner AL

    更新日期:2007-03-01 00:00:00

  • Correlation between vitamin D serum levels and passive smoking exposure in children with asthma.

    abstract:OBJECTIVE:To establish the relationship between vitamin D serum levels, pulmonary function, asthma control, and passive smoking exposure in children with asthma. METHODS:We studied the relationship between 25-hydroxy cholecalciferol (25[OH]D) concentrations and baseline spirometry and levels of asthma control, and the...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2018.39.4124

    authors: Chinellato I,Piazza M,Sandri M,Paiola G,Tezza G,Boner AL

    更新日期:2018-05-01 00:00:00

  • Evaluation of anxiety levels and factors associated with positive test results in patients with drug hypersensitivity.

    abstract:BACKGROUND:High anxiety has been reported in patients with drug hypersensitivity reaction (DHR); however, its relationship with the test results was not studied previously. OBJECTIVE:We aimed to investigate the association of patient anxiety with the results of drug tests together with the other contributing factors. ...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2015.36.3878

    authors: Comert S,Erdogan T,Demir AU,Karakaya G,Kalyoncu AF

    更新日期:2015-11-01 00:00:00

  • Emergency department treatment of adults with acute asthma exacerbations: effect on exhaled nitric oxide levels.

    abstract::Measurement of exhaled nitric oxide levels (eNO) from asthmatic patients is a noninvasive marker of airway inflammation in both adults and children and has been used as an outpatient measure of asthma control. We examined eNO in acute asthma exacerbations and how it is affected by treatment in the emergency departmen...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,随机对照试验

    doi:10.2500/aap.2012.33.3613

    authors: Silverberg JI,Rodenas M,Sinert R,Joks R

    更新日期:2012-11-01 00:00:00

  • Changing the route of immunotherapy administration: an 18-year survey in pediatric patients with allergic rhinitis and asthma.

    abstract::Immunotherapy can be administered either sublingually (sublingual immunotherapy [SLIT]) or subcutaneously (subcutaneous immunotherapy [SCIT]). The rate of route switching, required by patients, can provide an indirect evaluation of patients' preferences and adherence. The authors retrospectively reviewed patients' fil...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2013.34.3696

    authors: Pajno GB,Caminiti L,Passalacqua G

    更新日期:2013-11-01 00:00:00

  • Two puffs of 90 microg albuterol prior to 3% saline sputum induction results in less FEV-1 decline than single concentration 25 mg/ml methacholine challenge.

    abstract:BACKGROUND:Assessment of sputum eosinophilia has shown benefit in the diagnosis and monitoring of asthma. However, the possibility of bronchospasm related to the hypertonic saline used in sputum induction appears to have limited this procedure's acceptance in clinical practice. OBJECTIVE:Because the methacholine (MCH)...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2006.27.2900

    authors: Hagan JB,Madaan A,Kim CK

    更新日期:2006-09-01 00:00:00

  • Increased specific immunoglobulin G4 antibodies induced by natural exposure to ambrosia pollen in patients with allergy.

    abstract:BACKGROUND:Induction of specific immunoglobulin G4 (sIgG4) response (so-called blocking antibodies) in patients who receive specific immunotherapy (SIT) has been observed for many years. Although many other mechanisms have been identified as key regulators of immunologic processes in peripheral tolerance to allergens, ...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2016.37.3926

    authors: Ostojić V

    更新日期:2016-03-01 00:00:00

  • Biphasic reactions in children undergoing oral food challenges.

    abstract::Literature regarding biphasic reactions in the pediatric population is sparse. We aimed to determine the prevalence of biphasic reactions in children with food allergies undergoing oral food challenges (OFCs) and examine whether any clinical or treatment factors are associated with biphasic reactions. A retrospective ...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2013.34.3669

    authors: Lee J,Garrett JP,Brown-Whitehorn T,Spergel JM

    更新日期:2013-05-01 00:00:00

  • Effect of solar irradiation on serum specific immunoglobulin E to house-dust mite.

    abstract:BACKGROUND:The relationship between sensitization to Dermatophagoides species and solar irradiation, as reflected by vitamin D, remains elusive. OBJECTIVE:We investigated the lag time and the cumulative and maximum effects of exposure to solar irradiation on sensitization to house-dust mites. METHODS:A time series st...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,多中心研究

    doi:10.2500/aap.2015.36.3845

    authors: Lee SW,Cho E,Koh HY,Shin J,Baek JH,Shin YH,Jee HM,Kim HM,Han MY

    更新日期:2015-07-01 00:00:00

  • The role of outcome studies in allergy and clinical immunology.

    abstract::Outcomes research is becoming an integral part of the sweeping changes occurring in the U.S. health care system. By developing outcomes monitoring systems in allergic disorders, allergists will be able to collect information showing their commitment to excellent clinical care, which improves the patient's quality of l...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,评审

    doi:10.2500/108854196778606455

    authors: Blaiss MS

    更新日期:1996-11-01 00:00:00

  • Asthma persistence versus progression: does airway smooth muscle function predict irreversible airflow obstruction?

    abstract::Asthma, a disease characterized by airway inflammation and reversible bronchoconstriction, manifests a variety of phenotypes, and in some, but not all, asthma leads to a persistent and/or progressive loss of lung function. Conceptually, asthma persistence is identified by a stable decrement in lung function over time,...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,评审

    doi:10.2500/aap.2009.30.3202

    authors: Panettieri RA Jr

    更新日期:2009-03-01 00:00:00

  • Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.

    abstract::In a previous study, cetirizine and fexofenadine similarly relieved seasonal allergic rhinitis symptoms in the first 5 hours, but cetirizine was more effective at 21-24 hours postdose. This randomized, double-blind, placebo-controlled study compared the response to treatment between 5 and 12 hours. Eligible ragweed al...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,随机对照试验

    doi:

    authors: Day JH,Briscoe MP,Rafeiro E,Ratz JD,Ellis AK,Frankish CW,Chapman D,deGuia EC,Kramer B,Warner C

    更新日期:2005-07-01 00:00:00

  • Current management and use of oral immunotherapy in the United States for patients with peanut allergy.

    abstract::Background: Peanut allergy is a major health burden in the United States. Treatment is limited to avoidance and acute reaction management. No drug or medical product is approved for use as a peanut oral immunotherapy (POIT) agent. Objective: To examine peanut allergy diagnosis and treatment, peanut challenge protocols...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2019.40.4228

    authors: Blaiss MS,Tilles S,Petroni D,Zigmont E,Cassese M,Kwak B,Georgitseas N,Liebermann J

    更新日期:2019-07-23 00:00:00

  • Atopy patch testing for foods: a review of the literature.

    abstract::The atopy patch test (APT) was first reported in 1895 by the German dermatologist, Jadassohn and was used for evaluation of contact dermatitis. The first documented epicutaneous application of aeroallergens was by Rostenberg and Sulzbergen in 1937. Although others including Mitchell and Platts-Mills, further described...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,评审

    doi:10.2500/aap.2014.35.3797

    authors: Edwards KP,Martinez BA

    更新日期:2014-11-01 00:00:00

  • Effect of desloratadine on the control of morning symptoms in patients with seasonal and perennial allergic rhinitis.

    abstract::The symptoms of allergic rhinitis vary in severity over the course of the day and often are worse in the morning. This review focuses on data from clinical studies of the antihistamine desloratadine to establish whether it effectively controls the morning symptoms of allergic rhinitis. Studies of desloratadine in pati...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,评审

    doi:10.2500/aap.2006.27.2936

    authors: Schenkel EJ

    更新日期:2006-11-01 00:00:00

  • Serum clusterin level in children with atopic dermatitis.

    abstract:BACKGROUND:Atopic dermatitis (AD) is a chronic inflammatory skin disease. Clusterin is a sensitive cellular biosensor of oxidative stress and has been studied as a marker to assess inflammatory diseases. The clusterin levels in AD have not been evaluated thus far. OBJECTIVE:We evaluated serum clusterin levels in child...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2016.37.3953

    authors: Sol IS,Kim YH,Lee KE,Hong JY,Kim MN,Kim YS,Oh MS,Kim MJ,Yoon SH,Park YA,Kim KW,Sohn MH,Kim KE

    更新日期:2016-07-01 00:00:00

  • Mast cells in allergy and host defense.

    abstract::Mast cells have been implicated in the pathogenesis of allergic diseases and in inflammatory responses associated with pathological immune and disease-related processes including fibrosis, autoimmune pathology, and neoplasia. Recent findings in animal models of bacterial infection also suggest that mast cells may have...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,评审

    doi:10.2500/108854101778148764

    authors: Taylor ML,Metcalfe DD

    更新日期:2001-05-01 00:00:00